Andrew Long
Director/Board Member bei APRIA
Vermögen: 7 Mio $ am 31.03.2024
Profil
Andrew G.
Long is currently the CEO & Executive VP-Products & Healthcare Services at Owens & Minor, Inc. and the Director at Apria, Inc. Previously, he served as the Chief Executive Officer & Director at INSYS Therapeutics, Inc. and as the Senior Vice President-Global Finance at Patheon, Inc. Mr. Long completed his undergraduate degree at Indiana University and holds an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OWENS & MINOR, INC.
0,33% | 15.03.2024 | 249 780 ( 0,33% ) | 7 Mio $ | 31.03.2024 |
Aktive Positionen von Andrew Long
| Unternehmen | Position | Beginn |
|---|---|---|
| OWENS & MINOR, INC. | Corporate Officer/Principal | 12.10.2022 |
| APRIA | Director/Board Member | 29.03.2022 |
Ehemalige bekannte Positionen von Andrew Long
| Unternehmen | Position | Ende |
|---|---|---|
| INSYS THERAPEUTICS, INC. | Chief Executive Officer | 08.11.2019 |
| PATHEON, INC. | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Andrew Long
| Indiana University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OWENS & MINOR, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
Apria, Inc.
 Apria, Inc. Medical/Nursing ServicesHealth Services Apria, Inc. engages in the provision of healthcare services. The company was founded on March 22, 2018 and is headquartered in Indianapolis, IN. | Health Services |
